These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11995814)

  • 1. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.
    Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS
    J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
    Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
    Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells.
    Johnson MD; Woodard A; Kim P; Frexes-Steed M
    J Neurosurg; 2001 Feb; 94(2):293-300. PubMed ID: 11213968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.
    Johnson MD; Okedli E; Woodard A; Toms SA; Allen GS
    J Neurosurg; 2002 Sep; 97(3):668-75. PubMed ID: 12296652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MKP-3 regulates PDGF-BB effects and MAPK activation in meningioma cells.
    Johnson MD; Reeder JE; O'Connell M
    J Clin Neurosci; 2015 Apr; 22(4):752-7. PubMed ID: 25698542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition.
    Skaletz-Rorowski A; Müller JG; Kroke A; Waltenberger J; Pulawski E; Pinkernell K; Breithardt G
    Eur J Cell Biol; 2001 Mar; 80(3):207-12. PubMed ID: 11322384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.
    Johnson MD; O'Connell M; Facik M; Maurer P; Jahromi B; Pilcher W
    J Neurooncol; 2012 Mar; 107(1):121-31. PubMed ID: 21971737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY; Kim BC; Lee HS
    Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
    Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
    J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
    Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
    J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
    Li XA; Bianchi C; Sellke FW
    J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
    Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
    Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways.
    Chen JC; Huang KC; Lin WW
    Cell Signal; 2006 Jan; 18(1):32-9. PubMed ID: 16214041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways.
    Johnson MD; Okediji E; Woodard A
    J Neurooncol; 2004 Jan; 66(1-2):9-16. PubMed ID: 15015765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.
    Johnson MD; O'Connell M; Pilcher W
    J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
    Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
    J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
    Taylor CC
    Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.